Articles by Daniel Marsh
Johnson & Johnson Shares Retreat Amid Healthcare Sector Weakness
Johnson & Johnson stock declined 1.1% as healthcare stocks underperformed the broader market. Traders are eyeing upcoming U.S. jobs and inflation data for direction.
KLA Shares Hold Steady Near $1,440 Amid Chip Sector Recovery, Dividend Date Approaches
KLA Corp shares were nearly flat, trailing broader chip stock gains, as investors await key U.S. economic data. The company declared a $1.90 quarterly dividend payable in early March.
Costco Shares Retreat Amid Economic Data Watch, Bernstein Boosts Target
Costco stock declined in midday trading as investors awaited key U.S. economic reports, while Bernstein raised its price target on the retailer.
Caterpillar Shares Extend Rally as AI Demand Offsets Tariff Concerns
Caterpillar stock advanced 1.5% Monday, building on a 7.1% surge Friday that helped lift the Dow Jones Industrial Average above 50,000. Strong power segment sales driven by AI data center demand contrast with looming $2.6 billion in tariff costs.
Eddie Bauer Seeks Buyer for North American Stores Amid Bankruptcy Proceedings
Eddie Bauer is pursuing a buyer for its North American retail locations after filing for Chapter 11 bankruptcy protection in the U.S. and initiating similar proceedings in Canada. The company warns it may wind down store operations if a sale fails.
UnitedHealth Shares Edge Higher Amid Medicare Rate Scrutiny and Broader Market Volatility
UnitedHealth Group stock rose slightly as investors assessed a modest proposed Medicare Advantage payment increase for 2027. The healthcare giant continues to navigate pressure following a significant revenue warning earlier this year.
Visa Shares Decline Amid Broader Payment Sector Weakness
Visa shares fell 1.7% to $326.04 in Monday trading, underperforming the S&P 500's gain. Mastercard also dropped, while PayPal advanced.
Bloom Energy Surges 7% on Mizuho Target Hike; Focus Shifts to 2026 Margin Outlook
Bloom Energy shares rallied 7% after Mizuho raised its price target to $110, highlighting anticipated margin expansion in 2026. Investors are weighing the company's $20 billion backlog against execution risks.
Robinhood Shares Surge on Wolfe Research Upgrade Ahead of Earnings
Robinhood Markets stock gained 5.7% to $87.51 after Wolfe Research upgraded the brokerage to Outperform with a $125 target, citing improved earnings power and growth in prediction markets ahead of Tuesday's quarterly results.


